Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study status changed from Recruiting to Active, not recruiting, indicating no current enrollment. New sections for Contacts/Locations and Oversight were added to the study record.SummaryDifference0.9%

- Check21 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the page history. This does not alter study content or status.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding-related operating status notice was removed from the page header; this is an administrative update and does not alter study content or available data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedThe new screenshot shows only cosmetic/layout updates to the page header and navigation, and core study details appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdds a government-funding notice with operating-status guidance and announces a software version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%

- Check79 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.